Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Disparities in broad-based genomic sequencing for patients with advanced non-small cell lung cancer.

Riaz F, Presley CJ, Chiang AC, Longtine JA, Soulos PR, Adelson KB, Herbst RS, Nussbaum NC, Sorg RA, Abernethy AP, Agarwala V, Gross CP.

J Geriatr Oncol. 2019 Jul;10(4):669-672. doi: 10.1016/j.jgo.2019.01.016. Epub 2019 Feb 2. No abstract available.

PMID:
30718180
2.

Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non-Small Cell Lung Cancer in the Community Oncology Setting.

Presley CJ, Tang D, Soulos PR, Chiang AC, Longtine JA, Adelson KB, Herbst RS, Zhu W, Nussbaum NC, Sorg RA, Agarwala V, Abernethy AP, Gross CP.

JAMA. 2018 Aug 7;320(5):469-477. doi: 10.1001/jama.2018.9824.

3.

Laboratory practice guidelines for detecting and reporting JAK2 and MPL mutations in myeloproliferative neoplasms: a report of the Association for Molecular Pathology.

Gong JZ, Cook JR, Greiner TC, Hedvat C, Hill CE, Lim MS, Longtine JA, Sabath D, Wang YL; Association for Molecular Pathology.

J Mol Diagn. 2013 Nov;15(6):733-44. doi: 10.1016/j.jmoldx.2013.07.002. Epub 2013 Aug 24.

4.

No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from H&E-stained archival tissue sections.

Morikawa T, Shima K, Kuchiba A, Yamauchi M, Tanaka N, Imamura Y, Liao X, Qian ZR, Brahmandam M, Longtine JA, Lindeman NI, Fuchs CS, Ogino S.

Am J Clin Pathol. 2012 Jul;138(1):122-9. doi: 10.1309/AJCP28LAOOKSZSVW.

5.

Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation.

Weigert O, Kopp N, Lane AA, Yoda A, Dahlberg SE, Neuberg D, Bahar AY, Chapuy B, Kutok JL, Longtine JA, Kuo FC, Haley T, Salois M, Sullivan TJ, Fisher DC, Fox EA, Rodig SJ, Antin JH, Weinstock DM.

Cancer Discov. 2012 Jan;2(1):47-55. doi: 10.1158/2159-8290.CD-11-0208. Epub 2011 Dec 12.

6.

Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease.

Mega JL, Hochholzer W, Frelinger AL 3rd, Kluk MJ, Angiolillo DJ, Kereiakes DJ, Isserman S, Rogers WJ, Ruff CT, Contant C, Pencina MJ, Scirica BM, Longtine JA, Michelson AD, Sabatine MS.

JAMA. 2011 Nov 23;306(20):2221-8. doi: 10.1001/jama.2011.1703. Epub 2011 Nov 16.

PMID:
22088980
7.

Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas.

Tian Y, Rich BE, Vena N, Craig JM, Macconaill LE, Rajaram V, Goldman S, Taha H, Mahmoud M, Ozek M, Sav A, Longtine JA, Lindeman NI, Garraway LA, Ligon AH, Stiles CD, Santagata S, Chan JA, Kieran MW, Ligon KL.

J Mol Diagn. 2011 Nov;13(6):669-77. doi: 10.1016/j.jmoldx.2011.07.002. Epub 2011 Aug 30.

8.

Translocation t(1;9) is a recurrent cytogenetic abnormality associated with progression of essential thrombocythemia patients displaying the JAK2 V617F mutation.

Leon A, Staropoli JF, Hernandez JM, Longtine JA, Kuo FC, Dal Cin P.

Leuk Res. 2011 Sep;35(9):1188-92. doi: 10.1016/j.leukres.2011.02.001. Epub 2011 Mar 3.

PMID:
21376394
9.

Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantation.

Melanson SE, Stevenson K, Kim H, Antin JH, Court MH, Ho VT, Ritz J, Soiffer RJ, Kuo FC, Longtine JA, Jarolim P.

Am J Hematol. 2010 Dec;85(12):967-71. doi: 10.1002/ajh.21889. No abstract available.

10.

Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expression.

Bush ZM, Longtine JA, Cunningham T, Schiff D, Jane JA Jr, Vance ML, Thorner MO, Laws ER Jr, Lopes MB.

J Clin Endocrinol Metab. 2010 Nov;95(11):E280-90. doi: 10.1210/jc.2010-0441. Epub 2010 Jul 28.

11.

Florid reactive lymphoid hyperplasia of the lower female genital tract (lymphoma-like lesion): a benign condition that frequently harbors clonal immunoglobulin heavy chain gene rearrangements.

Geyer JT, Ferry JA, Harris NL, Young RH, Longtine JA, Zukerberg LR.

Am J Surg Pathol. 2010 Feb;34(2):161-8. doi: 10.1097/PAS.0b013e3181cc4f12.

PMID:
20087162
12.

Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background.

Geyer JT, Ferry JA, Longtine JA, Flotte TJ, Harris NL, Zukerberg LR.

Am J Clin Pathol. 2010 Jan;133(1):59-69. doi: 10.1309/AJCPW64FFBTTPKFN.

PMID:
20023259
13.

Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis.

Slack GW, Ferry JA, Hasserjian RP, Sohani AR, Longtine JA, Harris NL, Zukerberg LR.

Leuk Lymphoma. 2009 Jun;50(6):937-43. doi: 10.1080/10428190902930488.

PMID:
19455461
14.

HHV8-positive, EBV-positive Hodgkin lymphoma-like large B-cell lymphoma and HHV8-positive intravascular large B-cell lymphoma.

Ferry JA, Sohani AR, Longtine JA, Schwartz RA, Harris NL.

Mod Pathol. 2009 May;22(5):618-26. doi: 10.1038/modpathol.2009.36. Epub 2009 Mar 13.

15.

Carcinoma and multiple lymphomas in one patient: establishing the diagnoses and analyzing risk factors.

Cannizzo E, Sohani AR, Ferry JA, Hochberg EP, Kluk MJ, Dorn ME, Sadowski C, Bucci JJ, Ackerman AM, Longtine JA, Carulli G, Preffer FI.

J Hematop. 2009 Jul 23;2(3):163-70. doi: 10.1007/s12308-009-0041-0.

16.

CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature.

Rahemtullah A, Longtine JA, Harris NL, Dorn M, Zembowicz A, Quintanilla-Fend L, Preffer FI, Ferry JA.

Am J Surg Pathol. 2008 Nov;32(11):1593-607. doi: 10.1097/PAS.0b013e31817d7452.

PMID:
18753947
17.

PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations.

Nosho K, Kawasaki T, Ohnishi M, Suemoto Y, Kirkner GJ, Zepf D, Yan L, Longtine JA, Fuchs CS, Ogino S.

Neoplasia. 2008 Jun;10(6):534-41.

18.

Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults.

Kesari S, Schiff D, Henson JW, Muzikansky A, Gigas DC, Doherty L, Batchelor TT, Longtine JA, Ligon KL, Weaver S, Laforme A, Ramakrishna N, Black PM, Drappatz J, Ciampa A, Folkman J, Kieran M, Wen PY.

Neuro Oncol. 2008 Jun;10(3):300-8. doi: 10.1215/15228517-2008-005. Epub 2008 Apr 10.

19.

Clinical JAK2V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locations.

Abel GA, DeAngelo DJ, Connors JM, Sholl LM, McCaffrey RP, Longtine JA.

Am J Hematol. 2008 Jun;83(6):519-20. doi: 10.1002/ajh.21159. No abstract available.

20.

Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1.

Rodig SJ, Payne EG, Degar BA, Rollins B, Feldman AL, Jaffe ES, Androkites A, Silverman LB, Longtine JA, Kutok JL, Fleming MD, Aster JC.

Am J Hematol. 2008 Feb;83(2):116-21.

22.

Detection of BCL2 rearrangements in follicular lymphoma.

Aster JC, Longtine JA.

Am J Pathol. 2002 Mar;160(3):759-63. Review. No abstract available.

23.

Primary gastric plasmacytoma: a rare cause of hypertrophic gastritis in an adolescent.

Goyal A, Langer JC, Zutter M, Swanson P, Kraus MD, Bartlett N, Shackelford GD, Longtine JA, Perlmutter DH.

J Pediatr Gastroenterol Nutr. 1999 Oct;29(4):424-30.

PMID:
10512402
24.

Transfusion with blood from a donor with chronic myelogenous leukemia: persistence of the bcr/abl translocation in the recipient.

Vargas SO, Cannon ME, Benjamin RJ, Longtine JA.

Transfusion. 1999 Apr;39(4):387-91.

PMID:
10220265
25.
26.

T gamma/delta hepatosplenic lymphoma in a heart transplant patient after an Epstein-Barr virus positive lymphoproliferative disorder: a case report.

Kraus MD, Crawford DF, Kaleem Z, Shenoy S, MacArthur CA, Longtine JA.

Cancer. 1998 Mar 1;82(5):983-92.

PMID:
9486591
27.

Impact of activated protein C resistance on general vascular surgical patients.

Donaldson MC, Belkin M, Whittemore AD, Mannick JA, Longtine JA, Dorfman DM.

J Vasc Surg. 1997 Jun;25(6):1054-60.

28.

T-cell blast crisis in chronic myelogenous leukemia. Immunophenotypic and molecular biologic findings.

Dorfman DM, Longtine JA, Fox EA, Weinberg DS, Pinkus GS.

Am J Clin Pathol. 1997 Feb;107(2):168-76. Review.

PMID:
9024065
29.

Cytotoxic gamma delta I lymphocytes associated with an Epstein-Barr virus-induced posttransplantation lymphoproliferative disorder.

Rothenberg ME, Weber WE, Longtine JA, Hafler DA.

Clin Immunol Immunopathol. 1996 Sep;80(3 Pt 1):266-72.

PMID:
8811046
31.

Small lymphocytic non-Hodgkin's lymphoma of suppressor/cytotoxic T-cell phenotype [CD4(-), CD8(+)].

Dorfman DM, Longtine JA, Weinberg DS, Pinkus GS.

Hum Pathol. 1993 Nov;24(11):1253-6.

PMID:
8244326
32.
33.
34.

Clonal evidence for the induction of NKH1 on activated human thymocytes. Functional changes associated with antigen expression.

Caligiuri MA, Murray C, Levine H, Longtine JA, Ritz J.

Eur J Immunol. 1989 Sep;19(9):1735-9.

PMID:
2477257
35.

Silicone lymphadenopathy in a long distance runner: complication of a silastic prosthesis.

Rogers LA, Longtine JA, Garnick MB, Pinkus GS.

Hum Pathol. 1988 Oct;19(10):1237-9.

PMID:
3169730
36.

Lymphoma with clonal T-cell receptor gene rearrangement in a 25-year survivor of Hodgkin's disease.

Li FP, Gimbrere K, Ritz J, Saito H, Longtine JA.

Cancer. 1987 Nov 1;60(9):2213-8.

PMID:
3501968
37.

A low-temperature embedding colloidal gold technique for immunoelectron microscopy.

Warhol MJ, Longtine JA.

Diagn Immunol. 1986;4(1):47-55.

PMID:
3514072
39.

Immunohistochemical localization of smooth muscle myosin in normal human tissues.

Longtine JA, Pinkus GS, Fujiwara K, Corson JM.

J Histochem Cytochem. 1985 Mar;33(3):179-84.

PMID:
3882826

Supplemental Content

Loading ...
Support Center